EASTWOOD BIO-MEDICAL CANADA (EBM.CA) Stock Income Statement
TSX-V:EBM - TSX Venture Exchange - CA27783W1059 - Common Stock - Currency: CAD
| TTM (2025-4-30) | 2024 (2024-10-31) | 2023 (2023-10-31) | 2022 (2022-10-31) | 2021 (2021-10-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 657.40K | 702.10K | 867.90K | 1.30M | 981.10K | |||
| Cost Of Goods | 233.20K | 247.70K | 319.60K | 397.00K | 522.70K | |||
| Gross Profit | 424.20K | 454.40K | 548.40K | 902.70K | 458.40K | |||
| Operating Expenses | 851.00K | 883.20K | 1.08M | 1.05M | 1.08M | |||
| Selling, General, and Administrative Expenses | 751.90K | 775.70K | 974.70K | 940.80K | 976.10K | |||
| Operating Income | -426.90K | -428.80K | -534.20K | -144.90K | -623.00K | |||
| Interest Income/Expense | -22.90K | -7.20K | -12.40K | -5.60K | 0.00 | |||
| Other Income/Expense | N/A | N/A | 0.00 | 600.00 | 0.00 | |||
| Non Recurring Items | N/A | -19.90K | N/A | 0.00 | 19.40K | |||
| Income Before Taxes | -469.70K | -455.90K | -546.60K | -149.90K | -603.60K | |||
| Net Income | -469.60K | -455.90K | -546.60K | -149.90K | -603.60K | |||
| EBITDA | N/A | -321.30K | -426.30K | -38.00K | -517.70K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.00 | -0.01 | |||
| Statistics | ||||||||
| Gross Profit Margin | 64.53% | 64.72% | 63.19% | 69.45% | 46.72% | |||
| Profit Margin | -71.43% | -64.93% | -62.98% | -11.53% | -61.52% | |||
| Operating Profit Margin | -64.94% | -61.07% | -61.55% | -11.15% | -63.50% | |||
All data in CAD